Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer.

Date publication

novembre 2023

Journal

British journal of cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr GOBBO Jessica

Tous les auteurs :
Eslami-S Z, Cortés-Hernández LE, Sinoquet L, Gauthier L, Vautrot V, Cayrefourcq L, Avoscan L, Jacot W, Pouderoux S, Viala M, Thomas QD, Lamy PJ, Quantin X, Gobbo J, Alix-Panabières C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37973956

Résumé

Circulating tumour cells (CTCs), circulating tumour DNA (ctDNA), and extracellular vesicles (EVs) are minimally invasive liquid biopsy biomarkers. This study investigated whether they predict prognosis, alone or in combination, in heterogenous unbiased non-small cell lung cancer (NSCLC) patients.

Référence

Br J Cancer. 2023 11 16;: